期刊文献+

淋球菌43株对环丙沙星的耐药性及gyrA和parC基因突变的检测 被引量:1

Detection of 43 ciprofloxacin resistant gonococcal strains and mutations in gyrA and parC
下载PDF
导出
摘要 目的 :确定延安地区 2 0 0 2年分离的淋球菌对环丙沙星的耐药率和耐药菌株gyrA及parC基因突变情况 .方法 :从临床分离 4 3株淋球菌 ,进行药敏试验 .PCR扩增gyrA和parC基因 ,产物直接测序 .结果 :4 3株淋球菌菌株中 ,耐药株为 37株 ,耐药率为 86 % .耐药菌株gyrA基因的突变形式是Ser 91→Phe和Asp 95→Gly.parC基因最多见的突变是Asp 86→Asn和Ser 87→Arg,另外还检测到了Glu 91→Gly和Arg 1 1 6→Leu .gyrA突变见于所有的敏感性下降株和耐药株 ,parC突变见于耐药株 ,但有一株MIC为 0 .5 μg/mL的菌株也存在parC突变 .结论 AIM: To determine the occurrence of ciprofloxacin resistance among Neisseria gonorrhoeae strains isolated in Yan’an in 2002 and the frequency and patterns of mutations in gyrA and parC genes in these isolates. METHODS: Antibiotic susceptibility tests were performed in 43 isolates, gyrA and parC genes were amplified by PCR and the PCR products were directly sequenced. RESULTS: There were 37 strains resistant to ciprofloxacin in the isolates of gonococcal and the resisting frequency was 86%. Mutations in gyrA were Ser 91→Phe and Asp 95→Gly, and the most common mutations in parC were Asp 86→Asn and Ser 87→Arg. Glu 91→Gly and Arg 116→Leu were also detected in parC . Mutations in gyrA gene occurred in all the isolates with reduced susceptibility and resistance, and mutations in parC gene occurred in the isolates of resistance, but also occurred in one isolate with MIC 0.5 μg/mL. CONCLUSION: Mutations in gyrA and parC genes are mainly responsible for the gonococcal resistance to ciprofloxacin.
出处 《第四军医大学学报》 北大核心 2004年第11期1032-1034,共3页 Journal of the Fourth Military Medical University
关键词 淋球菌 GYRA PARC 环丙沙星耐药性 Nesseria gonorrhoea gyrA parC ciprofloxacin resistance
  • 相关文献

参考文献12

  • 1Deguchi T, Yasuda M, Asano M, et al. DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae[J]. Antimicrob Agents Chemother, 1995; 39(2): 561-563.
  • 2Su X, Lind I. Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998[J]. Antimicrob Agents Chemother, 2001; 45(1): 117-123.
  • 3Trees DL, Sandul AL, Whittington WL, et al. Identification of novel mutation patterns in the parC gene of ciprofloxacin-resistant isolates of Neisseria gonorrhoeae[J]. Antimicrob Agents Chemother, 1998; 42(8): 2103-2105.
  • 4Deguchi T, Yasuda M, Nakano M, et al. Quinolone-resistant Neisseria gonorrhoeae: Correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles[J]. Antimicrob Agents Chemother, 1996; 40(4): 1020-1023.
  • 5任小蓉 尚宏喜 肖生祥.陕西54株淋球菌对4种抗生素的敏感性测定[J].延安大学学报,2003,1(1):17-18.
  • 6National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: Twelfth informational supplement[Z]. NCCLS document M100-S12. Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards, 2002.
  • 7Tanaka M, Nakayama H, Haraoka M, et al. Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993-1998[J]. J Clin Microbiol, 2000; 38(5): 521-525.
  • 8Tanaka M, Nakayama H, Haraoka M, et al. Susceptibilities of Neisseria gonorrhoeae isolates containing amino acid substitutions in GyrA, with or without substitutions in ParC, to newer fluoroquinolones and other antibiotics[J]. Antimicrob Agents Chemother, 2000; 44(1): 192-195.
  • 9Belland RJ, Morrison SG, Ison CA, et al. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates[J]. Mol Microbiol, 1994; 14: 371-380.
  • 10Deguchi T, Yasuda M, Nakano M, et al. Uncommon occurrence of mutations in the gyrB gene associated with quinolone resistance in clinical isolates of Neisseria gonorrhoeae[J]. Antimicrob Agents Chemother, 1996; 40(2): 437-438.

同被引文献20

  • 1殷春红,夏培元,王仙园,罗羽.环丙沙星和司氟沙星体外诱导肺炎克雷伯菌产生耐药性的研究[J].中国药房,2005,16(20):1533-1535. 被引量:4
  • 2Belland RJ,Morrison SG,Ison CA,et al.Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluorquinolone-resistant isolates[J].Mol Microbiol,1994,14:371-380.
  • 3Deguchi T,Yasuda M,Nakano M,et al.Uncommon occurrence of mutations in the gyrB gene associated with quinolone-resistant in clinical isolates of Neisseria gonorrhoeae[J].Antimicrob Agents Chemother,1996,40(2):437-438.
  • 4Giles JA,Falconio J,Yuenger JD,et al.Quinolone resistance-determining region mutations and por type of Neisseria gonorrhoeae isolates:resistance surveillance and typing by molecular methodologies[J].J Infect Dis,2004,189(11):2085-2093.
  • 5Li X,Mafiano N,Rahal JJ,et al.Quinolone-resistant Haemophilus influenzae:determination of mutant selection window for ciprofloxacin,garenoxacin,levofloxacin,and moxifloxacin[J].Antimicrob-AgentsChemother,2004,48(11):4460-4462.
  • 6Belland RJ,Morrison SG,Ison C,et al.Neissefia gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates.Mol[J].Microbiol,1994,14:371-380.
  • 7Heisig P.Genetic evidence for a role of parC mutations in development of high-lever fluoroquinolone resistance in Escherichia coli[J].Atimicrob.Agents Chemother,1996,40:879-885.
  • 8Ysuda M,Fukuda H,Yokoi S,et al.In vitro swlection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and toposomerase Ⅳ[J].J Urol,2000,164:847-851.
  • 9Li X,ZHAO X,Drlica K.Selection of Streptococcus pneumoniae mutants having reduced susceptibility to levofloxacin and moxifloxacin.Antimicrob[J].Agents Chemother,2002,46:522-524.
  • 10Dong Y,Zhao X,Kreiswirth B,et al.Mutant prevention concertration as a measure of antibiotic potency:studies with clinical isolates of Mycobacterulosis.Antimicrob[J].Agents Chemother,2000,44:2581-2584.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部